Science Explorer Interactive view Map
Company · Cambridge · United States

Intellia Therapeutics (United States)

intelliatx.comROR OpenAlex
Research works
26
▲ 748% vs 2013–17
Citations
1.4k
54.2 per fractional work
Top-10% rate
10.5%
record average 16.5%
Open access
48%
world 28%

Not ranked overall: Intellia Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 9.93× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 3.37× its world share, 0 worksImmunology and Micro…Neuroscience: 0.35× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.60× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.01× its world share, 0 worksComputer ScienceEngineering: 0.03× its world share, 0 worksEngineeringEnvironmental Science: 0.15× its world share, 0 worksEnvironmental ScienceHealth Professions: 0.21× its world share, 0 worksHealth ProfessionsMedicine: 2.11× its world share, 6 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.9×. Every wedge is a field page.

Which keywords describe research at Intellia Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Genome Engineering, RNA-Guided, Cancer Immunotherapy, Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Gene Therapy and Genomic Integration.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 18 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Genome Engineering5▲ 323×1 topic
  2. RNA-Guided5▲ 323×1 topic
  3. Cancer Immunotherapy4▲ 113×2 topics
  4. Immunotherapy4▲ 24×2 topics
  5. CAR T Cells4▲ 352×1 topic
  6. Chimeric Antigen Receptor4▲ 352×1 topic
  7. Gene Therapy2▲ 31×3 topics
  8. Genomic Integration1▲ 53×2 topics
  9. AAV1▲ 74×1 topic
  10. Embryonic Stem Cells1▲ 65×2 topics
  11. Hereditary Angioedema1▲ 169×1 topic
  12. Kinin Receptor Family1▲ 169×1 topic
  13. Pluripotent Stem Cells1▲ 67×2 topics
  14. Transcriptional Regulation1▲ 18×2 topics
  15. Viral Vectors1▲ 74×1 topic
  16. Differentiation1▲ 57×2 topics
  17. Induced Pluripotent Stem Cells1▲ 118×1 topic
  18. Reprogramming1▲ 118×1 topic

Which research topics does Intellia Therapeutics (United States) publish most on?

By volume in 2022–2025: CRISPR and Genetic Engineering, CAR-T cell therapy research, Virus-based gene therapy research and Pluripotent Stem Cells Research.

CRISPR and Genetic Engin…4CRISPR and Genetic Engineering: 4 fractional worksCAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksVirus-based gene therapy…1Virus-based gene therapy research: 1 fractional worksPluripotent Stem Cells R…1Pluripotent Stem Cells Research: 1 fractional worksMonoclonal and Polyclona…0Monoclonal and Polyclonal Antibodies Research: 0 fractional worksNeurogenetic and Muscular Disorders Research: 0 fractional worksOrgan Transplantation Techniques and Outcomes: 0 fractional worksViral Infectious Diseases and Gene Expression in Insects: 0 fractional worksRenal Transplantation Outcomes and Treatments: 0 fractional worksMicroRNA in disease regulation: 0 fractional works
Molecular BiologyOncologyGeneticsRadiology, Nuclear Medicine and Imaging3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 4 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 Virus-based gene therapy research Genetics 1 works
  4. 4 Pluripotent Stem Cells Research Molecular Biology 1 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Neurogenetic and Muscular Disorders Research Genetics 0 works
  7. 7 Organ Transplantation Techniques and Outcomes Surgery 0 works
  8. 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  9. 9 Renal Transplantation Outcomes and Treatments Transplantation 0 works
  10. 10 MicroRNA in disease regulation Cancer Research 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.5%not open51.5%

World: 28% of research is openly available.

with international co-authors19.1%domestic only80.9%

World: 19% is written across borders.

How has Intellia Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 748% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.